Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Comment by birchjunkon Aug 17, 2011 5:21am
213 Views
Post# 18950354

RE: RE: Something Big Coming down the pipe ?

RE: RE: Something Big Coming down the pipe ?coutts struck the nail on the head.
Good dividend companies with a stable outlook have dividend yieldsields yields of about 8 %.
That places Automod in the $2.50 range.
The payout ratio is less than 30 % on their regular dividend of .20 per year.
Even paying out all of their annual cash flows of about $1 per share, they still will have .60  /share in cash remaining.
Look at it from earnings of .50 per share .
At 7.5 times with a regular dividend, they would be a $3.75 stock.
Sure, they will reach an accomodation with GM.
But thats pure gravy.
Bullboard Posts